| Date | Acquired company | Acquiring company | Amount | Related |
|---|---|---|---|---|
| 2011-02-09 | Kinaxo (Germany) | Evotec (Germany) | €12 million | Drug discovery |
| 2011-01-31 | UK manufacturing facility from RecipharmCobra Biologics | Oxford BioMedica (UK) | £1.9 million (€2.2 million) | Manufacturing |
| 2011-01-25 | Santhera Pharmaceuticals (Switzerland) | Newron Pharmaceuticals (Italy) | ||
| 2011-01-24 | Genoptix (USA) | Novartis (Switzerland) | $470 million (€344 million) | Personalized medicine |
| 2011-01-10 | Synosia Therapeutics (Switzerland) | Biotie Therapies (Finland) | € 93.6 million | |
| 0000-00-00 | ||||
| 0000-00-00 | Vtesse (USA - MD) | Sucampo Pharmaceuticals (USA - MA) | $200 million | Rare diseases - Genetic diseases |
| 0000-00-00 | Universal Cells (USA - WA) | Astellas Pharma (Japan) | up to $102.5 million | Technology - Services - Regenerative Medicine |
